Navigation Links
Avalon Pharmaceuticals to Present at the American Association for,Cancer Research 2007 Annual Meeting

GERMANTOWN, Md., April 10, 2007 /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. , today announced that AVN944 will be the subject of three poster presentations at the American Association for Cancer Research 2007 Annual Meeting to be held on April 14-18, 2007 in Los Angeles, Calif.

The first poster presented by Avalon, will review the data derived from the Avalon ongoing Phase I clinical trial of AVN944 for the treatment of hematological cancers. The poster is titled, "The Modulation of Gene Expression and Guanosine Pools by Inhibition of Inosine Monophosphate Dehydrogenase (IMPDH); correlating In Vitro Cell Resistance with Biomarker Response in Patient Samples from the Phase I Trial." This poster will provide data from clinical samples that correlate IMPDH inhibition, GTP pool suppression, and associated changes in tumor cell gene expression. The presentation will be Monday, April 16, 2007 from 8 a.m. until noon Pacific Time.

The second Avalon poster presentation is titled, "Antiangiogenic Properties of AVN944, A Potent Inhibitor of IMPDH." The poster will describe in vitro and in vivo experiments that reveal the effects of AVN944 on blood vessel formation. The presentation will be on Tuesday, April 17, 2007 from 8 a.m. until noon Pacific Time.

Another poster that will discuss AVN944 will be presented by the lab of Dr. Beverly Mitchell of Stanford University. The poster is titled, "GTP depletion induces translocation of TIF-IA and PAF53, inhibition of pre-rRNA synthesis and dislocation of nucleolar proteins." The presentation cites AVN944 as a compound that has effects on rRNA inhibition and nucleolar protein translocation. The poster presentation will be Tuesday, April 17, 2007 from 1 p.m. until 5 p.m. Pacific Time.

All three posters are in the Experimental and Molecular Therapeutics Poster Sessions.

AVN944 is an oral small molecule drug candidate that inhibits inosin
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
2. Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:5/22/2013)... and MUNICH , May 22, 2013 /PRNewswire/ ... marketer of transcatheter aortic valve implantation (TAVI) systems for the ... results of the J enaValve Eval U ation of ... Pa T ients with S E vere Ao R tic ... . JUPITER is a post-market registry to evaluate five-year long ...
(Date:5/22/2013)... May 22, 2013  The Lupus Research Institute (LRI) ... advancing new treatments for lupus nephritis, a serious kidney ... patients. The conference launched a new international alliance of ... Trials Network (LNTN). More than 50 of ... came together to focus on two critical questions: 1) ...
(Date:5/22/2013)... -- The new 13-valent pneumococcal conjugate vaccine (PCV13) appears ... prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), ... Vaccine. The U.S. Food and Drug Administration ... series of trials. These trials found that PCV13, which ... the previously used PCV7, did not increase the risk ...
Breaking Medicine Technology:First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4
(Date:5/22/2013)... May 22, 2013 Jury deliberations are now ... involving a da Vinci lawsuit, Bernstein Liebhard LLP ... of a man who allegedly died of da Vinci surgery ... million in damages from Intuitive Surgical, Inc. Among other ... program for the da Vinci Surgical System in its efforts ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 The Muscular ... against muscular dystrophy at the annual Charlotte Muscle Team ... to help Charlotte-area families living with muscle disease. ... year's event to support MDA families,” said MDA Divisional ... who were partnered with a "Buddy" to make their ...
(Date:5/22/2013)... Zensah® Compression Apparel released a statement regarding ... "Breast pain while running affects one-third of women ... According to the article, a British study surveyed over ... from breast pain while running but do not wear ... , Zensah emphasizes the importance for women to wear ...
(Date:5/22/2013)... there is a gender gap when it comes to ... that does not appear to exist in children in ... levels of self-regulation than boys. Self-regulation is defined as ... directions, and persist on a task. It has been ... studies by Oregon State University researchers. , In ...
(Date:5/22/2013)... People in the United States have been taking ... In much of the world, water shortages are normal and ... She warns against taking water for granted and provides ways ... easily in the United States. , Sharon Kleyne is host ... heard live or by podcast on World Talk Radio, Voice ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Charlotte Muscle Team Event Raises $300,000 in the Fight Against Muscle Disease 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2
... flight surgeons supporting Wyle and its NASA Bioastronautics Contract have ... NASA announced last week that Dr. Kjell Lindgren and Dr. ... Texas Medical Branch (UTMB) in the Department of Preventive ... from a pool of 3,565 applicants. UTMB is one of ...
... N.J., July 1 Zufall Health Center, a federally ... launched the nation,s first eco-friendly mobile medical unit. , ... needed, affordable health care to low-income, mostly uninsured residents ... officials commemorated the launch at a ribbon cutting ceremony ...
... a higher risk of hospitalization or death due to cirrhosis ... with a lower risk. These findings are in the July ... Wiley & Sons on behalf of the American Association for ... available online at Wiley Interscience ( www.interscience.wiley.com ). ...
... mother of an autistic child joined Consumer Watchdog and ... California Department of Managed Health Care ("DMHC"), the Schwarzenegger ... insurers. The suit alleges that the DMHC has wrongfully ... treatments, resulting in the denial of critically needed, medically ...
... , TeamHealth Demonstrates Ongoing Commitment to Patient Care through ... July 1 TeamHealth announced today that it has ... safety. On July 1, its patient safety organization -- ... by the Agency for Healthcare Research and Quality (AHRQ), ...
... , To Expand Access to Its Research, HealthTech Joins With Public ... CalRHIO Board of Directors has appointed Molly Joel Coye, MD, MPH, ... California statewide information exchange founded in 2005. Dr. Coye was ... of the Board of Directors since 2007. , , "Molly ...
Cached Medicine News:Health News:Two Flight Surgeons Supporting Wyle's Bioastronautics Contract Selected for New Astronaut Class 2Health News:Two Flight Surgeons Supporting Wyle's Bioastronautics Contract Selected for New Astronaut Class 3Health News:Nation's First Eco-Friendly Mobile Health Van Launched by New Jersey Non-Profit Health Center 2Health News:Nation's First Eco-Friendly Mobile Health Van Launched by New Jersey Non-Profit Health Center 3Health News:Study examines dietary influences of liver disease 2Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 2Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 3Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 4Health News:Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 5Health News:TeamHealth Recognized by National Quality Agency 2Health News:TeamHealth Recognized by National Quality Agency 3Health News:Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO 2Health News:Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO 3
... is the first compact, broad menu clinical ... in any treatment setting. Care givers can ... with less than one minute of hands-on ... in quality to larger, expensive laboratory analyzers ...
... lens, doctors have to make a trade off ... Now, with the Digital Wide Field lens ... both in one lens. This lens provides ... non-contact lens paired with the higher magnification required ...
RCB™ Rotator Cuff Buttress is a completely resorbable plate that will alleviate suture migration in open or mini-Open rotator cuff repairs....
... USS Sports Medicine™ POLYSORB™ Soft Tissue Anchor 3 ... attach soft tissue to bone using sutures. The ... hole in the bone, and is used to ... of a resorbable copolymer, derived from glycolide and ...
Medicine Products: